How iRhythm’s AI-Powered Zio Monitor Is Transforming Heart Health & Patient Care

Cyberattacks and Threats in Medical Devices: What Medtech Companies Must Know Now

In just the past two months, Stryker, Intuitive Surgical, and Medtronic – three of the world's Top 100 Medical Device companies [https://www.mddionline.com/business/top-40-medical-device-companies] – have faced cyberattacks. Why are medtech companies becoming prime targets for hackers? What makes medical devices so vulnerable? And how is the FDA responding? In this episode of Let's Talk Medtech, Naomi Schwartz [https://www.linkedin.com/in/naomi-schwartz-7843068/], VP of Regulatory Strategy at Medcrypt, [https://www.medcrypt.com/] breaks down: ✅ The anatomy of recent cyberattacks on leading medtech firms ✅ Why hackers are targeting the medical device industry ✅ What these breaches mean for patient safety and data security ✅ FDA's new cybersecurity requirements and what companies must do now

How iRhythm’s AI-Powered Zio Monitor Is Transforming Heart Health & Patient Care

Discover how iRhythm is changing arrhythmia detection and patient care with CFO Daniel Wilson. In this episode of "Let's Talk MedTech," we explore the groundbreaking Zio monitor, a wearable device that uses FDA-cleared AI to provide continuous 14-day heart monitoring. Learn how iRhythm Technologies is addressing the challenges of undiagnosed arrhythmias, expanding into primary care, and even venturing into sleep disorder diagnostics. With nearly 3 million patients served annually and more than 140 peer-reviewed studies, iRhythm is at the forefront of predictive healthcare. Subscribe for more insights into the medical device and diagnostics industry! #MedTech #iRhythm #AI #Wearables #HealthcareInnovation

Shattering the Product Adoption Lie in the Medical Device Industry

Holley Miller [https://www.linkedin.com/in/holleymalia/], founder and President of Grey Matter Marketing, is our guest on this episode of Let's Talk Medtech to discuss why it's so crucial to have the right message for your product.

Let's Talk Women's Health in 2026

Join Marissa Fayer [https://www.linkedin.com/in/marissa-fayer/], CEO of HerHealthEQ [https://www.herhealtheq.org/] and DeepLook Medical, [https://www.deeplookmedical.com/] as she explores the future of women's health and what it could look like in 2026 in this insightful episode of Let's Talk Medtech.

Augurex Redefines Autoimmune Disease Detection

Augurex [https://augurex.com/] is a commercial-stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, enabling the optimization and personalization of treatment options for patients. Neil Klompas, the firm’s CEO, joins us for this episode of Let’s Talk Medtech to discuss how the company aims to accelerate the diagnosis of the disease and enhance autoimmune diagnostics for patients.